ReacX Pharmaceuticals, Inc.
PrivateLast Round
Grant
Feb 5, 2025
Company Overview
ReacX Pharmaceuticals, Inc. is a biotechnology company that develops therapeutics using its proprietary ProNeura drug delivery technology for the treatment of chronic conditions such as opioid addiction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReacX Pharmaceuticals, Inc. Comparables
Compare ReacX Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Akyso Therapeutics | 87% | |
| Hera Health Solutions | 85% | |
| Delpor | 84% |
ReacX Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 5, 2025 |
ReacX Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2025
$10.35M grant received from National Institute on Drug Abuse.
ReacX Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ReacX Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is ReacX Pharmaceuticals, Inc. a public or private company?
ReacX Pharmaceuticals, Inc. is a private company.
What is the current stock price of ReacX Pharmaceuticals, Inc.?
ReacX Pharmaceuticals, Inc. is a private company with no public stock price. Caplight tracks ReacX Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is ReacX Pharmaceuticals, Inc. worth (valuation)?
Valuation information for ReacX Pharmaceuticals, Inc. is not publicly available.
Can I buy ReacX Pharmaceuticals, Inc. stock?
ReacX Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ReacX Pharmaceuticals, Inc.'s last funding round?
ReacX Pharmaceuticals, Inc.'s most recent funding round was Grant on February 5, 2025.
Who are the main investors in ReacX Pharmaceuticals, Inc.?
Key investors in ReacX Pharmaceuticals, Inc. include National Institute on Drug Abuse.
Will ReacX Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for ReacX Pharmaceuticals, Inc..
How can I track ReacX Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ReacX Pharmaceuticals, Inc.'s secondary market activity and sign up for updates.